AIM

AIM ImmunoTech (AIM)

About AIM ImmunoTech (AIM)

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.

Details

Daily high
$0.28
Daily low
$0.26
Price at open
$0.26
52 Week High
$0.62
52 Week Low
$0.21
Market cap
16.8M
Dividend yield
0.00%
Volume
70,729
Avg. volume
415,360
P/E ratio
-.47

AIM ImmunoTech News

Details

Daily high
$0.28
Daily low
$0.26
Price at open
$0.26
52 Week High
$0.62
52 Week Low
$0.21
Market cap
16.8M
Dividend yield
0.00%
Volume
70,729
Avg. volume
415,360
P/E ratio
-.47